MedTrace Logo

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828

NCT05834595 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2023-08-25

No results posted yet for this study

Summary

A clinical trial to compare the pharmacokinetic and safety of CKD-828

Conditions

Interventions

DRUG

CKD-828, D064, D701

QD, PO

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2023-07-18
Completion
2023-07-26

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05834595 on ClinicalTrials.gov